Browse > Article
http://dx.doi.org/10.4062/biomolther.2011.19.1.102

Essential Oil of Thujopsis dolobrata Suppresses Atopic Dermatitis-Like Skin Lesions in NC/Nga Mice  

Nam, Kung-Woo (Natural Products Research Institute, College of Pharmacy, Seoul National University)
Noh, Jae-Kyu (Natural Products Research Institute, College of Pharmacy, Seoul National University)
Kim, Su-Kwan (G&G Co., Ltd.)
Lee, Sung-Jin (Department of Animal Biotechnology, Kangwon National University)
Kim, Kyeong-Ho (College of Pharmacy, Kangwon National University)
Oh, Ki-Bong (School of Agricultural Biotechnology, Seoul National University)
Shin, Jong-Heon (Natural Products Research Institute, College of Pharmacy, Seoul National University)
Mar, Woong-Chon (Natural Products Research Institute, College of Pharmacy, Seoul National University)
Publication Information
Biomolecules & Therapeutics / v.19, no.1, 2011 , pp. 102-108 More about this Journal
Abstract
We examined the effects of essential oil from Thujopsis dolobrata Sieb. et Zucc. var. hondai Makino (EOTD) (Cupressaceae) on atopic dermatitis (AD)-like skin lesions in NC/Nga mice. Treatment with EOTD twice daily for two weeks ameliorate AD-like skin lesions induced by DNCB (2,4 dinitrochlorobenzene), and clinical scores were reduced to 7.29, 7.07, and 4.5 points in the groups treated with 1.5%, 3.0%, and 6.0% extract (p<0.01) respectively, from the 15.0 score obtained using vehicle. EOTD inhibited the infiltration of mast cells into the AD-like skin lesion in NC/Nga mice (p<0.01) and also reduced serum histamine and IgE levels (p<0.05). Furthermore, it dose-dependently inhibited the release of beta-hexosaminidase from rat basophilic leukemia RBL 2H3 cells. These results indicate that EOTD reduces AD-like skin lesions by inhibiting the production of IgE and histamine, and, thus, IgE-mediated degranulation.
Keywords
Thujopsis dolobrata; Atopic dermatitis; Beta-hexosaminidase; NC/Nga mouse; IgE;
Citations & Related Records

Times Cited By Web Of Science : 3  (Related Records In Web of Science)
Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Chen, L., Lin, S. X., Overbergh, L., Mathieu, C. and Chan, L. S. (2005) The disease progression in the keratin 14 IL-4-transgenic mouse model of atopic dermatitis parallels the up-regulation of B cell activation molecules, proliferation and surface and serum IgE. Clin. Exp. Immunol. 142, 21-30.   DOI
2 Chen, L., Overbergh, L., Mathieu, C. and Chan, L. S. (2008) The development of atopic dermatitis is independent of Immunoglobulin E up-regulation in the K14-IL-4 SKH1 transgenic mouse model. Clin. Exp. Allergy 38, 1367-1380.   DOI
3 Choi, J. J., Park, B., Kim, D. H., Pyo, M. Y., Choi, S., Son, M. and Jin, M. (2008) Blockade of atopic dermatitis-like skin lesions by DA-9102, a natural medicine isolated from Actinidia arguta, in the Mg-deficiency induced dermatitis model of hairless rats. Exp. Biol. Med.(Maywood) 233, 1026-1034.   DOI
4 Elias, P. M. (2008) Barrier repair trumps immunology in the pathogenesis and therapy of atopic dermatitis. Drug Discov. Today Dis. Mech. 5, e33-e38.   DOI
5 Ference, J. D. and Last, A. R. (2009) Choosing topical corticosteroids. Am. Fam. Physician. 79, 135-140.
6 Fischer, M., Harvima, I. T., Carvalho, R. F., Moller, C., Naukkarinen, A., Enblad, G. and Nilsson, G. (2006) Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion. J. Clin. Invest. 116, 2748-2756 .   DOI
7 Alenius, H., Laouini, D., Woodward, A., Mizoguchi, E., Bhan, A. K., Castigli, E., Oettgen, H. C. and Geha, R. S. (2002) Mast cells regulate IFN-gamma expression in the skin and circulating IgE levels in allergen-induced skin inflammation. J. Allergy Clin. Immunol. 109, 106-113.   DOI
8 Amon, U., Dieckmann, D., Nitschke, M., Wehrhahn, C. and Wolff, H. H. (1995) The role of basophilic leukocytes in inflammatory skin diseases. Hautarzt 46, 234-239.   DOI
9 Morita, Y., Matsumura, E., Tsujibo, H., Yasuda, M., Okabe, T., Sakagami, Y., Kumeda, Y., Ishida, N. and Inamor, Y. (2002) Biological activity of 4-acetyltropolone, the minor component of Thujopsis dolabrata SIeb. et Zucc. hondai MakBiol. Pharm. Bull. 25, 981-985.   DOI
10 Morita, Y., Matsumura, E., Okabe, T., Shibata, M., Sugiura, M., Ohe, T., Tsujibo, H., Ishida, N. and Inamori, Y. (2003) Biological activity of tropolone. Biol. Pharm. Bull. 26, 1487-1490.   DOI
11 Saeki, H., Furue, M., Furukawa, F., Hide, M., Ohtsuki, M., Katayama, I., Sasaki, R., Suto, H. and Takehara, K. (2009) Guidelines for management of atopic dermatitis. J. Dermatol. 36, 563-577.   DOI
12 Noshita, T., Ishiai, S., Furukido, T. and Funayama, S. (2009) Isolation of (-)-4'-demethyl traxillagenin from Thujopsis dolabrata Sieb. et Zucc. var. hondai Makino. J. Nat. Med. 63, 105-106.   DOI
13 Pariser, D. (2009) Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: focus on percutaneous absorption. Am. J. Ther. 16, 264-273.   DOI
14 Qi, X. F., Kim, D. H., Yoon, Y. S., Li, J. H., Jin, D., Deung, Y. K. and Lee, K. J. (2009) Effects of Bambusae caulis in Liquamen on the development of atopic dermatitis-like skin lesions in hairless mice. J. Ethnopharmacol. 123, 195-200.   DOI
15 Takahashi, K., Nagahama, S., Nakashima, T. and Suenaga, H. (2001) Chemotaxonomy on the leaf constituents of Thujopsis dolabrata Sieb. et Zucc.-Analysis of neutral extracts (diterpene hydrocarbon). Biochem. Syst. Ecol. 29, 839-848.   DOI
16 Yamaji, K., Mori, S., Akiyama, M., Kato, A. and Nakashima, T. (2007) The antifungal compound totarol of Thujopsis dolabrata var. hondai seeds selects for fungi on seedling root surfaces. J. Chem. Ecol. 33, 2254-2265.   DOI
17 Kawakami, T., Ando, T., Kimura, M., Wilson, B. S. and Kawakami, Y. (2009) Mast cells in atopic dermatitis. Curr. Opin. Immunol. 21, 666-678.   DOI
18 Leung, D. Y. (1995) Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J. Allergy Clin. Immunol. 96, 302-318.   DOI
19 Leung, D. Y. and Bieber, T. (2003) Atopic dermatitis. Lancet 361, 151-160.   DOI
20 Levin, C. and Maibach, H. (2002) Exploration of "alternative" and "natural" drugs in dermatology. Arch. Dermatol. 138, 207-211.   DOI
21 Marciniak, J., Zalewska, A., Popko, J. and Zwierz, K. (2006) Optimization of an enzymatic method for the determination of lysosomal Nacetyl-beta-D-hexosaminidase and beta-glucuronidase in synovial fluid. Clin. Chem. Lab. Med. 44, 933-937.   DOI
22 Matsubara, T., Aoki, N., Hino, S., Okajima, T., Nadano, D. and Matsuda, T. (2009) Serum and monoclonal immunoglobulin E antibodies from NC/Nga mice with severe atopic-like dermatitis recognize an auto-antigen, histone H3. Clin. Exp. Allergy 39, 579-590.   DOI
23 Matsumoto, M., Ra, C., Kawamoto, K., Sato, H., Itakura, A., Sawada, J., Ushio, H., Suto, H., Mitsuishi, K., Hikasa, Y. and Matsuda, H. (1999) IgE hyperproduction through enhanced tyrosine phosphorylation of Janus kinase 3 in NC/Nga mice, a model for human atopic dermatitis. J. Immunol. 162, 1056-1063.
24 Milgrom, H. (2002) Attainments in atop: special aspects of allergy and IgE. Adv. Pediatr. 49, 273-297.
25 Morita, Y., Matsumura, E., Okabe, T., Fukui, T., Ohe, T., Ishida, N. and Inamori, Y. (2004) Biological activity of beta-dolabrin, gamma-thujaplicin, and 4-acetyltropolone, hinokitiol-related compounds. Biol. Pharm. Bull. 27, 1666-1669.   DOI
26 Barker, J. N., Palmer, C. N., Zhao, Y., Liao, H., Hull, P. R., Lee, S. P., Allen, M. H., Meggitt, S. J., Reynolds, N. J., Trembath, R. C. and McLean, W. H. (2007) Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. J. Invest. Dermatol. 127, 564-567.   DOI
27 Brenninkmeijer, E. E., Legierse, C. M., Sillevis Smitt, J. H., Last, B. F., Grootenhuis, M. A. and Bos, J. D. (2009) The course of life of patients with childhood atopic dermatitis. Pediatr. Dermatol. 26, 14-22.   DOI